193 related articles for article (PubMed ID: 34764984)
21. Integrative Multi-Omics Analysis of Identified SKA3 as a Candidate Oncogene Correlates with Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma.
Lin Y; An J; Zhuo X; Qiu Y; Xie W; Yao W; Yin D; Wu L; Lei D; Li C; Xie Y; Hu A; Li S
Int J Gen Med; 2022; 15():4635-4647. PubMed ID: 35535142
[TBL] [Abstract][Full Text] [Related]
22. TMPRSS2 Serves as a Prognostic Biomarker and Correlated With Immune Infiltrates in Breast Invasive Cancer and Lung Adenocarcinoma.
Xiao X; Shan H; Niu Y; Wang P; Li D; Zhang Y; Wang J; Wu Y; Jiang H
Front Mol Biosci; 2022; 9():647826. PubMed ID: 35558557
[TBL] [Abstract][Full Text] [Related]
23. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
Guo L; Li X; Liu R; Chen Y; Ren C; Du S
Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
[TBL] [Abstract][Full Text] [Related]
24. TCN1 is a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma.
Li H; Guo L; Cai Z
World J Surg Oncol; 2022 Mar; 20(1):83. PubMed ID: 35287670
[TBL] [Abstract][Full Text] [Related]
25. High expression of PIMREG predicts poor survival outcomes and is correlated with immune infiltrates in lung adenocarcinoma.
Jiang F; Liang M; Huang X; Shi W; Wang Y
PeerJ; 2021; 9():e11697. PubMed ID: 34268011
[TBL] [Abstract][Full Text] [Related]
26. CCND2 is a prognostic biomarker and correlates with immune infiltration in lung adenocarcinoma.
Jia E; Shi X; Xue J
Transl Cancer Res; 2024 Mar; 13(3):1241-1251. PubMed ID: 38617521
[TBL] [Abstract][Full Text] [Related]
27. Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics.
Guo W; Sun S; Guo L; Song P; Xue X; Zhang H; Zhang G; Wang Z; Qiu B; Tan F; Xue Q; Gao Y; Gao S; He J
J Cancer Res Clin Oncol; 2020 Apr; 146(4):821-841. PubMed ID: 32103339
[TBL] [Abstract][Full Text] [Related]
28. Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma.
Luo L; Zheng Y; Lin Z; Li X; Li X; Li M; Cui L; Luo H
J Immunol Res; 2021; 2021():6647122. PubMed ID: 33928169
[TBL] [Abstract][Full Text] [Related]
29. Decreased expression of JAK1 associated with immune infiltration and poor prognosis in lung adenocarcinoma.
Cai J; Deng H; Luo L; You L; Liao H; Zheng Y
Aging (Albany NY); 2020 Dec; 13(2):2073-2088. PubMed ID: 33323549
[TBL] [Abstract][Full Text] [Related]
30. Decreased zinc-fingers and homeoboxes family expression was associated with unfavorable outcomes and immune infiltration in lung adenocarcinoma.
Tao D; Tan J; Zhang N; Yang D; Jiang Y; Zhou W; Wang Y; Wu Y
Transl Cancer Res; 2023 Jun; 12(6):1422-1440. PubMed ID: 37434685
[TBL] [Abstract][Full Text] [Related]
31. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
32. Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on TCGA and GEO databases.
Zhao J; Guo C; Ma Z; Liu H; Yang C; Li S
Lung Cancer; 2020 Nov; 149():90-96. PubMed ID: 33002836
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive Analysis of the Immune and Prognostic Implication of COL6A6 in Lung Adenocarcinoma.
Ma Y; Qiu M; Guo H; Chen H; Li J; Li X; Yang F
Front Oncol; 2021; 11():633420. PubMed ID: 33747955
[TBL] [Abstract][Full Text] [Related]
34. The low expression of NUP62CL indicates good prognosis and high level of immune infiltration in lung adenocarcinoma.
Ren S; Wang W; Zhang C; Sun Y; Sun M; Wang Y; Zhang X; Lu B; Yao L
Cancer Med; 2021 May; 10(10):3403-3412. PubMed ID: 33934535
[TBL] [Abstract][Full Text] [Related]
35. BTN3A2 Expression Is Connected With Favorable Prognosis and High Infiltrating Immune in Lung Adenocarcinoma.
Lin Y; Zhou H; Li S
Front Genet; 2022; 13():848476. PubMed ID: 35873496
[No Abstract] [Full Text] [Related]
36. Pan-cancer analysis identifies
Yang H; Wei X; Zhang L; Xiang L; Wang P
Transl Cancer Res; 2022 Aug; 11(8):2902-2916. PubMed ID: 36093552
[TBL] [Abstract][Full Text] [Related]
37. INHA acts as a novel and potential biomarker in lung adenocarcinoma and shapes the immune-suppressive tumor microenvironment.
Zhang X; Zhang X; Jiang D; Zheng W; Wang H; Tian Y; Cheng B
Transl Oncol; 2023 Jul; 33():101679. PubMed ID: 37105130
[TBL] [Abstract][Full Text] [Related]
38. CSF2RB Is a Unique Biomarker and Correlated With Immune Infiltrates in Lung Adenocarcinoma.
Zhu N; Yang Y; Wang H; Tang P; Zhang H; Sun H; Gong L; Yu Z
Front Oncol; 2022; 12():822849. PubMed ID: 35574409
[TBL] [Abstract][Full Text] [Related]
39. Downregulated Expression of CLEC9A as Novel Biomarkers for Lung Adenocarcinoma.
Miao F; Lou Z; Ji S; Wang D; Sun Y; Liu H; Yang C
Front Oncol; 2021; 11():682814. PubMed ID: 34616670
[TBL] [Abstract][Full Text] [Related]
40. Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures.
Huo C; Zhang MY; Li R; Liu TT; Li JP; Qu YQ
Front Cell Dev Biol; 2021; 9():645482. PubMed ID: 34368114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]